The basement membrane matrix in malignancy

被引:186
作者
Engbring, JA [1 ]
Kleinman, HK [1 ]
机构
[1] NIDCR, Craniofacial Dev Biol & Regenerat Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA
关键词
basement membrane; extracellular matrix; laminin; metastasis;
D O I
10.1002/path.1396
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cancer is the second most common cause of death among Americans, although for several age groups it ranks first. Most of these deaths are not due to the primary tumour but rather to tumour cell metastases to distant organs. There are many steps that lead to metastasis, all of which are being studied with the goal of preventing these fatalities. Normally, cells attach to the extracellular matrix to maintain tissue integrity. During cancer progression, cells become more motile and acquire invasive qualities. Tumour cells move along blood and lymph vessels or invade into them to travel to distant sites. Then, the tumour cells must attach to the vessel wall, extravasate from the vessel, invade the new tissue, proliferate, and form a secondary tumour. Angiogenesis, the formation of new blood vessels, is critical to survival of these cells at the new site and is also important for primary tumour growth and spread. Tumour cell metastasis is a complex cascade of sequential steps, each of which is not yet fully understood. Progress has been made in identifying several key activators, one of which is the extracellular matrix. A major tumour promoter is the glycoprotein laminin, which is predominantly found in the extracellular matrix produced by endothelial and epithelial cells. This review will follow the metastatic process with particular attention to the effect of laminin on tumour cells. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:465 / 470
页数:6
相关论文
共 77 条
  • [41] Lui D., 2002, SEMIN THROMB HEMOST, V28, P67
  • [42] Identification of laminin α1 and β1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting
    Malinda, KM
    Nomizu, M
    Chung, M
    Delgado, M
    Kuratomi, Y
    Yamada, Y
    Kleinman, HK
    Ponce, ML
    [J]. FASEB JOURNAL, 1999, 13 (01) : 53 - 62
  • [43] Matrix metalloproteinases: structures, evolution, and diversification
    Massova, I
    Kotra, LP
    Fridman, R
    Mobashery, S
    [J]. FASEB JOURNAL, 1998, 12 (12) : 1075 - 1095
  • [44] Cancer biology: Extracellular proteinases in malignancy
    Matrisian, LM
    [J]. CURRENT BIOLOGY, 1999, 9 (20) : R776 - R778
  • [45] Matrix metalloproteinases: they're not just for matrix anymore!
    McCawley, LJ
    Matrisian, LM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2001, 13 (05) : 534 - 540
  • [46] The 67 kDa laminin receptor as a prognostic factor in human cancer
    Ménard, S
    Tagliabue, E
    Colnaghi, MI
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 137 - 145
  • [47] Integrin laminin receptors and breast carcinoma progression
    Mercurio, AM
    Bachelder, RE
    Chung, J
    O'Connor, KL
    Rabinovitz, I
    Shaw, LM
    Tani, T
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (03) : 299 - 309
  • [48] Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan
    Mongiat, M
    Sweeney, SM
    San Antonio, JD
    Fu, J
    Iozzo, RV
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (06) : 4238 - 4249
  • [49] Nachtigal P, 2001, Acta Medica (Hradec Kralove), V44, P83
  • [50] ANGIOSTATIN - A NOVEL ANGIOGENESIS INHIBITOR THAT MEDIATES THE SUPPRESSION OF METASTASES BY A LEWIS LUNG-CARCINOMA
    OREILLY, MS
    HOLMGREN, L
    SHING, Y
    CHEN, C
    ROSENTHAL, RA
    MOSES, M
    LANE, WS
    CAO, YH
    SAGE, EH
    FOLKMAN, J
    [J]. CELL, 1994, 79 (02) : 315 - 328